GoodRx Holdings shares are trading higher after TD Cowen upgraded the stock from Market Perform to Outperform and raised its price target from $6.5 to $12.
Portfolio Pulse from Benzinga Newsdesk
TD Cowen has upgraded GoodRx Holdings' stock from Market Perform to Outperform and raised its price target from $6.5 to $12. As a result, GoodRx Holdings shares are trading higher.
July 31, 2023 | 2:20 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
GoodRx Holdings' stock has been upgraded by TD Cowen from Market Perform to Outperform, with a price target increase from $6.5 to $12. This has led to a rise in the company's share price.
The upgrade from TD Cowen is a positive signal for GoodRx Holdings, indicating increased confidence in the company's performance. The raised price target suggests that the analyst sees potential for significant growth in the stock's value, which is likely driving the increase in share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100